Xanthogranulomatous epithelial tumour of the calcaneus in a 32-year-old female: a rare entity.

Skeletal RadiolAug 5, 2026 (epub)

Darshana Sanghvi, Amrit Kaur Kaler, Manit Gundavda et al.

✦ AI-curated · Sources linked

Case in brief

A 32-year-old woman presented with 10 months of heel pain. Imaging showed a lytic lesion in the calcaneus, with giant cell tumour of bone and solid aneurysmal bone cyst among the initial considerations. Histology showed a bland lesion containing xanthomatous histiocytes and giant cells; diffuse cytokeratin positivity on immunohistochemistry prompted further characterization. Molecular testing confirmed an HMGA2::NCOR2 fusion and found no H3F3A or USP6 alterations, establishing primary intraosseous xanthogranulomatous epithelial tumour.

What made this case unusual

The calcaneal lesion mimicked more familiar giant cell-rich bone tumours radiologically and histologically, while diffuse cytokeratin staining and molecular confirmation identified XGET.

Diagnostic / clinical pearl

For a giant cell-rich lytic bone lesion with diffuse cytokeratin positivity, molecular testing for HMGA2::NCOR2 can help distinguish XGET from GCTB and solid aneurysmal bone cyst.

Source

Published in Skeletal Radiol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.